Immunization funding pulled by Trump administration, Minneapolis Health Department says
The Brief
The Minneapolis Health Department said federal immunization funding has been pulled back by the Trump administration.
The funding was reportedly used to provide free vaccine education, clinics and immunization records for public schools.
Three Minneapolis Health Department employees are also impacted and are currently being funded by other sources.
MINNEAPOLIS (FOX 9) - Federal COVID-19 immunization funding has been pulled back by the Trump administration, the Minneapolis Health Department announced on Wednesday.
The Minneapolis Health Department said the result is that vaccination clinics and immunization education "must cease immediately."
What they're saying
The funding was used to support the city's vaccination efforts, which included community education, free pediatric and adult clinics as well as updating the immunization records for Minneapolis Public School students.
The city said the contacts it held with MHealth Fairview, Odam Medical Clinic and neighborhood HealthSource will cease immediately.
The lack of funding also impacts three Minneapolis Health Department employees, who city officials say are currently being funded through other sources while other options are evaluated.
Minneapolis Health Commissioner Damón Chaplin shared the following written statements:
"The impact on our community is substantial. We are canceling five free vaccine clinics scheduled for April, and the future of our vaccine services in underserved communities is uncertain. Decisions at the federal level threaten public health now and in the future."
The commissioner also said, "Decisions at the federal level are impacting lives and hurting employees dedicated to making Minneapolis a healthy place to live. Their work on our vaccine program has saved lives and prevented illnesses throughout the city. Eliminating federal support for these positions hurts our community and puts more burden on Minneapolis to deliver our mission to improve the health and well-being of every community member."
By the numbers
The Minneapolis Health Department said it partnered with community organizations to host 87 vaccine clinics in "underserved communities", which provided more than 800 COVID-19 vaccines, more than 700 flu shots, and more than 500 MPOX vaccines.
The health department said it also provided 21 vaccine clinics, with 1,475 vaccinations administered and 501 patients served with 12 vaccines available to youth.
The Minneapolis Health Department adds that as of Sept. 2024, only 70% of the city's 6-year-olds were up to date on their childhood vaccinations.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Omada Health IPO signals healthier market, avoids 'down-round' trend
The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic conditions like diabetes and hypertension between office visits, closed its first trading day on Friday at $23 a share, a 21% jump from the IPO price of $19. The IPO valued the company just above $1 billion (excluding employee options), a figure that's nearly identical to Omada's last private valuation of $1 billion set in its previous VC round. The debut is one of the first among recent IPOs that was not a so-called down-round. Many of the latest public listings, including Hinge, ServiceTitan, and Reddit, priced below their private market highs, though have faired well as public companies. For founder and CEO Sean Duffy, the successful public offering validates his decision to start a company that he believed the market desperately needed. In 2011, he dropped out of Harvard Medical School after realizing that chronic illness patients required more continuous support than the existing healthcare system delivered. Before the offering, he owned 4.1% of the company, according to Omada's offering document. Other significant shareholders included Revelation Partners (10.9%), US Venture Partners (9.9%), Andreessen Horowitz (9.6%), and FMR (9.3%). Duffy told TechCrunch that over his 14-year journey as a founder, he had many harrowing moments. "I didn't think our series A was going to come together because we were working on this commercial deal that didn't materialize, and that spooked one investor," he said. "As a young business, something tries to kill you every month," he continued. "And then as the business grows, it turns into like every quarter or six months, year, two years." One of the recent challenges for many digital health businesses is navigating the "collapse" of the market post-COVID boom. Omada steered through the turbulent times by seeking new, rising markets. It recently expanded its offerings to include diet management support for GLP-1 patients.
Yahoo
4 hours ago
- Yahoo
Pharmaceutical company AstraZeneca sues Utah Attorney General over discount medication law
SALT LAKE CITY () — The pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah Insurance Commissioner Jon Pike over a recent law that is intended to allow more pharmacies to have access to drug discount programs. In a lawsuit filed May 23, AstraZeneca alleges that Utah SB 69 is unconstitutional. The law was introduced and passed in the 2025 General Assembly, and it went into effect on May 7. The law prohibits drug manufacturers from restricting pharmacies from working with 340B entities, which help pharmacies and patients access medications at a discounted price. Senator Lee responds to the Trump-Musk feud The 340B Drug Pricing Program is a that 'enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services,' according to the Health Resources and Services Administration (HRSA) website. It means that drug manufacturers participating in Medicaid agree to provide 'outpatient drugs to covered entities at significantly reduced prices.' All organizations need to be registered and enrolled in the 340B program in order to purchase discounted medications. The law that established the 340B Program, Section 340B(a)(4) of the Public Health Service Act, specified certain types of for the program, such as medical centers that serve rural and other underserved communities and clinics that specialize in particular diseases like HIV/AIDS. SB 69 expands the scope, requiring drug manufacturers to provide the discounts to third-party pharmacies that are contracting with 340B entities, and this is what AstraZeneca is claiming is unconstitutional in its lawsuit. Utah House Republicans elect new leadership members The lawsuit states that because price controls 'disincentivize innovation and destabilize markets,' Congress chose to specifically limit the types of organizations that are eligible in Section 340B. The suit notes that for-profit pharmacies like Walgreens or CVS were not included as eligible, and there have already been several federal court cases ruling that block efforts to require drug manufacturers to provide discounts to contracted pharmacies. AstraZeneca claims in its suit that SB 69 'requires pharmaceutical manufacturers to offer 340B-discounted pricing for sales at an unlimited number of contract pharmacies,' expanding 340B discounts to 'an entirely new category of transactions not covered by Section 340B itself.' The suit alleges that SB 69 directly conflicts with federal law requirements, and therefore, it cannot be enforced against Astrazeneca or other drug manufacturers. AstraZeneca is asking the court to declare SB 69 unconstitutional and to order that Utah AG Derek Brown and Insurance Commissioner Jon Pike not enforce the law against AstraZeneca. Musk floats 'The American Party' after Trump tiff Myths VS Facts: What health officials want you to know about the MMR vaccine Good4Utah Road Tour: Willard Bay State Park Lori Vallow Daybell back in court, charged with conspiracy to murder ex nephew-in-law Man charged with assault for allegedly attacking and strangling neighbor Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
5 hours ago
- Yahoo
Migratory birds develop antibodies to bird flu, officials say
(WAVY) – Wildlife officials are keeping a close eye on the spread of avian influenza after along the North Carolina coast earlier this year — most of them brown pelicans. The outbreak has since been linked to the H5N1 strain of bird flu, a virus that continues to mutate and occasionally jump to other species, raising concern among experts. Miranda Turner, a wildlife health biologist with the North Carolina Wildlife Resources Commission, said the area is a prime wintering ground for birds — making it easier for disease to spread. 'When you bring a lot of animals together and you have them traveling from different locations, it's a really good way to transmit diseases,' Turner said. In Hampton Roads, bird flu outbreaks aren't new. Lisa Barlow, president of T recalls treating sick and dying Canada geese during a 2021 outbreak on the Lafayette River. 'We dealt with about three to four dozen Canada geese that came in sick and dying,' Barlow said. 'Only six survived the flu, and even those had to be euthanized due to severe neurological symptoms.' Barlow described birds arriving unable to hold their heads up, their beaks caked in mud. Many died within 24 hours. As the virus continues to affect wildlife, it's not just birds at risk. , including seals, cats and even cattle. Experts say it's mutated at least several times since it was first identified. 'I mean, anything that can do that — it's kind of frightening, but amazing,' Barlow said. Despite the concerning spread, health officials emphasize the risk to humans remains low. According to the Centers for Disease Control and Prevention, 70 human cases have been reported nationwide, including one death. Most infections have been among people with repeated exposure to infected animals, such as poultry or dairy farm workers. 'There's really low risk,' Turner said. 'Still, it's a good idea to clean bird feeders regularly and wear gloves or a mask if you handle injured wildlife.' Barlow also urges caution for those who come across sick birds. 'If you do want to help, wear gloves, protect yourself,' she said. 'Common sense goes a long way.' Meanwhile, as migratory birds continue to interact and spread the virus, some are developing natural antibodies, according to Turner. 'They're bouncing back and creating herd immunity,' she said. Last week, the Associated Press reported the in funding meant to support Moderna's development of a bird flu vaccine. The vaccine, which uses mRNA technology similar to the COVID-19 vaccine, had shown early promise in clinical trials. For now, wildlife officials say they expect to see more outbreaks in the years ahead, especially during peak migration periods. 'Because this virus is so common in migratory birds, it is likely that we will continue to see cases here and there every winter,' Turner said. As of right now, there have been no confirmed human cases of H5N1 in Virginia and although the risk remains low for humans, for birds it can be extremely deadly – leading to large die-off events like the ones we saw near Cape Hatteras. 'Unfortunately, this was the first kind of major large scale mortality event… while it looks really bad at that small scale of seeing 300 brown pelicans die – it's not impacting their population as a whole or the species as a whole,' adds Turner. Turner also explains that the surviving pelicans are still there, 'The brown pelicans that did survive that event were still nesting on that island successfully and are doing well. So really, it's a short scale kind of scary looking event, but nothing that raises alarm for biologists in the long term.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
